Funding helped outcomes journal CE Measure make debut

Share this article:
Funding from Novo Nordisk and Medscape/WebMD helped outcomes journal CE Measure make its October debut. Organizers of the journal, a joint publication of UMDNJ and Carden Jennings Publishing, had struggled to raise the $100,000 startup cost (MM&M July 2006).
Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZeneca beefs up respiratory portfolio

AstraZeneca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.